🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "focused steps to address household expense challenges" in the forthcoming financial statement.

During an interview with media outlets, she stated that curbing price rises is a joint duty of both the administration and the Bank of England.

The United Kingdom's inflation rate is projected to be the most elevated among the Group of Seven advanced economies this calendar year and the following year.

Potential Utility Cost Interventions

Reports indicate the government could take action to bring down utility costs, for example by slashing the present 5% level of VAT applied on energy.

Another possibility is to reduce some of the regulatory levies presently added to household expenses.

Budgetary Constraints and Analyst Expectations

The government will receive the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much room there is for such measures.

The consensus from most economists is that Reeves will have to declare tax rises or expenditure reductions in order to meet her declared debt limits.

Previously on Thursday, calculations showed there was a twenty-two billion pound deficit for the chancellor to fill, which is at the lower end of forecasts.

"It is a joint responsibility between the Bank of England and the government to bear down further on some of the drivers of inflation," the Chancellor stated to reporters in Washington, at the yearly gatherings of the IMF and World Bank.

Tax Pledges and International Concerns

While a great deal of the focus has been on probable tax increases, the chancellor said the most recent information from the OBR had not changed her pledge to election pledges not to raise rates on earnings tax, VAT or social security contributions.

She attributed an "uncertain global environment" with rising international and trade tensions for the Budget revenue measures, likely to be focused on those "with the broadest shoulders."

International Economic Disputes

Commenting on apprehensions about the UK's economic relations with China she said: "The UK's national security invariably take priority."

Last week's statement by China to increase export controls on critical minerals and other materials that are key for high-technology production led American leader Donald Trump to propose an further 100% import tax on imports from China, increasing the prospect of an all-out trade war between the two economic giants.

The US Treasury Secretary labeled China's move "commercial pressure" and "a global supply chain power grab."

Asked about considering the US offer to participate in its dispute with China, the Chancellor said she was "deeply worried" by China's measures and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the decision was "harmful for the global economy and causes further obstacles."

"In my view there are sectors where we should confront Chinese policies, but there are also valuable prospects to trade with Chinese markets, including banking sector and other sectors of the economic system. We've got to maintain that balance appropriate."

The Treasury chief also affirmed she was collaborating with international partners "on our own essential resources strategy, so that we are less reliant."

NHS Medicine Pricing and Funding

Reeves also acknowledged that the cost the National Health Service pays for pharmaceuticals could rise as a consequence of current discussions with the US government and its pharmaceutical firms, in return for lower tariffs and funding.

A number of the world's largest drug companies have said lately that they are either pausing or abandoning operations in the United Kingdom, with several attributing the insufficient payments they are obtaining.

Last month, the government science advisor said the cost the health service spends on medicines would need to rise to halt firms and drug research funding leaving the UK.

Reeves stated to media: "We have seen as a result of the payment system, that medical research, recent pharmaceuticals have not been offered in the UK in the manner that they are in other EU nations."

"The objective is to ensure that patients receiving treatment from the NHS are can obtain the best critical drugs in the globe. And so we are examining all of that, and... aiming to attract more capital into Britain."